ArticleTranslational oncology2021

Cytotoxicity of combinations of the pan-KRAS inhibitor BAY-293 against primary non-small lung cancer cells.

Adelina Plangger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.